SACHS: 15th Annual European Life Sciences CEO Forum
1-2 MAR 2022 | DIGITAL
1-2 MAR 2022 | DIGITAL
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]
For the UK to fulfill its international aspirations, tapping into the soft power of its influential diaspora, including the 3,000+ life science leaders within the British Educated Life Scientists (BELS) global community, should be a high priority for UK organisations across our sector—government, quasi-government orgs, industry, academia, charities, healthcare orgs, service providers, incubators, investors, etc. Soft power […]